Ontology highlight
ABSTRACT: Introduction
Despite the growing number of oral agents available for cancer treatment, their efficacy may be reduced due to the lack of adherence, inappropriate adverse event self-management and arbitrary dose adjustment. The management of anticancer therapies could exponentially benefit from the introduction of mobile health technologies in a highly integrated electronic oncology system.Methods and analysis
We plan to customise and fine-tune an existing monitoring TreC platform used in different chronic diseases in the oncology setting. This project follows a multistep approach with two major purposes: 1. participatory design techniques driven by Health Literacy and Patient Reported Outcomes principles in order to adapt the system to the oncology setting involving patients and healthcare providers; 2. a prospective training-validation, interventional, non-pharmacological, multicentre study on a series of consecutive patients with cancer (20 and 60 patients in the training and validation steps, respectively) in order to assess system capability, usability and acceptability. The novel Onco-TreC 2.0 is expected to contribute to improving the adherence and safety of cancer care, promoting patient empowerment and patient-doctor communication.Ethics and dissemination
Ethical approval was obtained from the Independent Ethics Committees of the participating institutions (CEIIAV protocol Number 2549/2015; reference Number 1315-PU). Informed consent will be obtained from all study participants. Findings will be disseminated through peer-reviewed journals, conferences and event presentations.Trial registration number
ClinicalTrials.gov (NCT02921724); (Pre-results). Other study ID Number: IRST100.18.
SUBMITTER: Passardi A
PROVIDER: S-EPMC5729988 | biostudies-literature | 2017 May
REPOSITORIES: biostudies-literature
Passardi Alessandro A Rizzo Mimma M Maines Francesca F Tondini Carlo C Zambelli Alberto A Vespignani Roberto R Andreis Daniele D Massa Ilaria I Dianti Marco M Forti Stefano S Piras Enrico Maria EM Eccher Claudio C
BMJ open 20170529 5
<h4>Introduction</h4>Despite the growing number of oral agents available for cancer treatment, their efficacy may be reduced due to the lack of adherence, inappropriate adverse event self-management and arbitrary dose adjustment. The management of anticancer therapies could exponentially benefit from the introduction of mobile health technologies in a highly integrated electronic oncology system.<h4>Methods and analysis</h4>We plan to customise and fine-tune an existing monitoring TreC platform ...[more]